ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 154 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $411,000 | -22.0% | 11,220 | -0.9% | 0.01% | -23.1% |
| Q2 2019 | $527,000 | -8.0% | 11,322 | -20.7% | 0.01% | -7.1% |
| Q1 2019 | $573,000 | -9.9% | 14,280 | +3.2% | 0.01% | -22.2% |
| Q4 2018 | $636,000 | -13.9% | 13,838 | -16.9% | 0.02% | 0.0% |
| Q3 2018 | $739,000 | +749.4% | 16,660 | +653.8% | 0.02% | +800.0% |
| Q2 2018 | $87,000 | -94.4% | 2,210 | -89.7% | 0.00% | -95.2% |
| Q1 2018 | $1,552,000 | +353.8% | 21,454 | +312.4% | 0.04% | +366.7% |
| Q4 2017 | $342,000 | -24.0% | 5,202 | -42.0% | 0.01% | -30.8% |
| Q3 2017 | $450,000 | -3.4% | 8,976 | -10.8% | 0.01% | -7.1% |
| Q2 2017 | $466,000 | -1.9% | 10,064 | -25.3% | 0.01% | -6.7% |
| Q1 2017 | $475,000 | +181.1% | 13,464 | 0.0% | 0.02% | +150.0% |
| Q4 2016 | $169,000 | – | 13,464 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |